Interpreting subgroup analyses: is a school-based asthma treatment program's effect modified by secondhand smoke exposure?
Bundy
David G
DG
University of North Carolina, Chapel Hill 27599-7105, USA. david_bundy@med.unc.edu
Berkoff
Molly Curtin
MC
Ito
Kristin E
KE
Rosenthal
Marjorie S
MS
Weinberger
Morris
M
D000730:Androstadienes / Q000627:therapeutic use*; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D000068298:Fluticasone; D006801:Humans; D012107:Research Design; D012572:School Health Services; D014028:Tobacco Smoke Pollution; D016896:Treatment Outcome
D000730:Androstadienes; D018927:Anti-Asthmatic Agents; D000893:Anti-Inflammatory Agents; D014028:Tobacco Smoke Pollution; D000068298:Fluticasone